Deletion of the SOCS3 Gene in Liver Parenchymal Cells Promotes Hepatitis–Induced Hepatocarcinogenesis
- 1 July 2006
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 131 (1) , 179-193
- https://doi.org/10.1053/j.gastro.2006.04.025
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal Of Cancer, 2005
- Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signalingNature Medicine, 2005
- Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinomaOncogene, 2005
- Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancerNature Clinical Practice Oncology, 2005
- SOCS3 Is a Physiological Negative Regulator for Granulopoiesis and Granulocyte Colony-stimulating Factor Receptor SignalingJournal of Biological Chemistry, 2004
- Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular TransformationThe Journal of Experimental Medicine, 2002
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- IL-6 up-regulates Mcl-1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathwayEuropean Journal of Immunology, 1999
- Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-ApoptosisImmunity, 1996
- Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCCLiver International, 1987